# Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial

> **NCT03584854** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 100 (actual)

## Conditions studied

- Postpartum Hemorrhage
- Uterine Atony

## Interventions

- **DRUG:** 15-methyl prostaglandin F2α
- **DRUG:** Methylergonovine Maleate

## Key facts

- **NCT ID:** NCT03584854
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2022-05-22
- **Final completion:** 2022-06-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03584854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03584854, "Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03584854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*